ASCIA HAE Position Paper and Management Plan
Notice from Cipla regarding supply of icatibant
Notice from Takeda regarding delisting of Firazyr (icatibant) from PBS in Australia.www.allergy.org.au/about-ascia/info-updates/product-supply-update-danazol
New ASCIA HAE Management Plan 2020 (with type in fields), which replaces the ASCIA HAE Action Plan.
ASCIA HAE Management Plan 2020129.80 KB
New ASCIA HAE Case Peer Review Form (with type in fields), which needs to be completed when requesting prophylaxis dose increases using a new treatment option - Berinert® SC.
ASCIA HAE Case Peer Review Form 202091.69 KB
HAE Australasia is a support organisation for people with HAE and their carers in Australia and New Zealand. For more information visit www.haeaustralasia.org.au
For information about how ASCIA information for health professionals is developed go to: www.allergy.org.au/about-ascia/website-information
Content updated November 2020